Qiagen N.V.

NYSE: QGEN · Real-Time Price · USD
42.79
-0.34 (-0.79%)
At close: May 05, 2025, 3:59 PM
42.81
0.05%
After-hours: May 05, 2025, 04:05 PM EDT
-0.79%
Bid 42.1
Market Cap 9.25B
Revenue (ttm) 1.98B
Net Income (ttm) 83.59M
EPS (ttm) 0.38
PE Ratio (ttm) 112.61
Forward PE 17.1
Analyst Hold
Ask 44.8
Volume 852,134
Avg. Volume (20D) 1,343,445
Open 43.22
Previous Close 43.13
Day's Range 42.74 - 43.45
52-Week Range 37.63 - 47.93
Beta 0.62

About QGEN

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology con...

Sector Healthcare
IPO Date Jun 28, 1996
Employees 5,067
Stock Exchange NYSE
Ticker Symbol QGEN
Full Company Profile

Analyst Forecast

According to 8 analyst ratings, the average rating for QGEN stock is "Hold." The 12-month stock price forecast is $50.47, which is an increase of 17.95% from the latest price.

Stock Forecasts

Next Earnings Release

Qiagen N.V. is scheduled to release its earnings on May 7, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago
+5.36%
Qiagen shares are trading higher following the com... Unlock content with Pro Subscription